Učitavanje...
Drug resistance to targeted therapies: Déjà vu all over again
A major limitation of targeted anticancer therapies is intrinsic or acquired resistance. This review emphasizes similarities in the mechanisms of resistance to endocrine therapies in breast cancer and those seen with the new generation of targeted cancer therapeutics. Resistance to single‐agent canc...
Spremljeno u:
| Izdano u: | Mol Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528618/ https://ncbi.nlm.nih.gov/pubmed/24910388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.05.004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|